Published in Cochrane Database Syst Rev on January 21, 2009
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology (2014) 1.19
Clinical applications of intravenous immunoglobulins in neurology. Clin Exp Immunol (2009) 0.92
Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins. Biologics (2010) 0.86
VIP-expressing dendritic cells protect against spontaneous autoimmune peripheral polyneuropathy. Mol Ther (2014) 0.84
Therapeutic plasma exchange in neurology: 2012. J Clin Apher (2013) 0.82
Intravenous immunoglobulin as clinical immune-modulating therapy. CMAJ (2015) 0.81
Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside. Semin Neurol (2012) 0.80
New Frontiers in Subcutaneous Immunoglobulin Treatment. Biol Ther (2011) 0.78
Intravenous immunoglobulin for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Open Med (2010) 0.75
Clinical applications of immunoglobulin: update. Rev Bras Hematol Hemoter (2011) 0.75
Peripheral neuropathies: current evidence for alternative treatment regimens and treatment combinations. Clin Exp Immunol (2014) 0.75
Intravenous immunoglobulin treatment in chronic neurological diseases: do we have maintenance dose right? Autoimmune Dis (2014) 0.75
AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy. Gene Ther (2015) 0.75
Acute pandysautonomia--restitutio ad integrum by high prednisolone therapy. Wien Klin Wochenschr (2011) 0.75
Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med (2004) 7.87
Antibiotic guidelines and antibiotic use in adult bacterial meningitis in The Netherlands. J Antimicrob Chemother (2002) 1.90
Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab (2008) 1.71
Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure. J Neurol Neurosurg Psychiatry (2013) 1.64
Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial. Lancet Neurol (2010) 1.63
Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke (2008) 1.59
Serum IgG levels in IV immunoglobulin treated chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry (2013) 1.57
Effect of nimodipine on outcome in patients with traumatic subarachnoid haemorrhage: a systematic review. Lancet Neurol (2006) 1.49
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2013) 1.45
Randomized, controlled trial of miglustat in Gaucher's disease type 3. Ann Neurol (2008) 1.42
Eugen Bleuler (1857-1939), an early pioneer of evidence based medicine. J Neurol Neurosurg Psychiatry (2012) 1.40
Clinical evaluation and investigation of neuropathy. J Neurol Neurosurg Psychiatry (2003) 1.33
The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study. Brain (2009) 1.25
Subcutaneous immunoglobulin therapy for multifocal motor neuropathy. J Peripher Nerv Syst (2009) 1.21
Cognitive impairment in adults with good recovery after bacterial meningitis. J Infect Dis (2002) 1.20
Coexistent hereditary and inflammatory neuropathy. Brain (2003) 1.15
Autonomic neuropathy in Fabry disease: a prospective study using the Autonomic Symptom Profile and cardiovascular autonomic function tests. BMC Neurol (2010) 1.13
Decision making in interhospital transport of critically ill patients: national questionnaire survey among critical care physicians. Intensive Care Med (2008) 1.13
Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial. BMC Med (2009) 1.12
Group a streptococcal meningitis in adults: report of 41 cases and a review of the literature. Clin Infect Dis (2002) 1.09
Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial. J Cereb Blood Flow Metab (2009) 1.08
Miglustat (Zavesca) in type 1 Gaucher disease: 5-year results of a post-authorisation safety surveillance programme. Pharmacoepidemiol Drug Saf (2009) 1.03
Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Cochrane Database Syst Rev (2012) 1.03
Cognitive change in newly-diagnosed patients with Parkinson's disease: a 5-year follow-up study. J Int Neuropsychol Soc (2013) 1.03
Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based. Blood (2008) 1.01
Door-to-needle time and the proportion of patients receiving intravenous thrombolysis in acute ischemic stroke: uniform interpretation and reporting. Stroke (2013) 1.01
Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study. Brain (2010) 1.00
The Academic Medical Center Linear Disability Score (ALDS) item bank: item response theory analysis in a mixed patient population. Health Qual Life Outcomes (2005) 1.00
Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress. Alzheimer Dis Assoc Disord (2009) 0.99
Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia. J Neurol (2004) 0.97
PATCH: platelet transfusion in cerebral haemorrhage: study protocol for a multicentre, randomised, controlled trial. BMC Neurol (2010) 0.95
Small fiber neuropathy in Fabry disease. Mol Genet Metab (2012) 0.93
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev (2013) 0.93
Early onset neuropathy in a compound form of Charcot-Marie-Tooth disease. Ann Neurol (2005) 0.93
The relation between small nerve fibre function, age, disease severity and pain in Fabry disease. Eur J Pain (2011) 0.92
Familial cortical myoclonic tremor with epilepsy: a single syndromic classification for a group of pedigrees bearing common features. Mov Disord (2005) 0.92
Hyperglycemia and clinical outcome in aneurysmal subarachnoid hemorrhage: a meta-analysis. Stroke (2009) 0.90
The use of an item response theory-based disability item bank across diseases: accounting for differential item functioning. J Clin Epidemiol (2009) 0.88
Manual dexterity in hereditary motor and sensory neuropathy type 1a: severity of limitations and feasibility and reliability of two assessment instruments. J Rehabil Med (2008) 0.87
Increased cortisol levels are associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neurocrit Care (2010) 0.87
Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice. J Peripher Nerv Syst (2010) 0.86
The impact of disease-related impairments on disability and health-related quality of life: a systematic review. BMC Med Res Methodol (2007) 0.86
Discussions about treatment restrictions in chronic neurologic diseases: a structured review. Neurology (2012) 0.86
Cutaneous sensibility and peripheral nerve function in patients with unmedicated essential hypertension. Psychophysiology (2007) 0.86
Dihydropyridine calcium antagonists increase fibrinolytic activity: a systematic review. J Cereb Blood Flow Metab (2006) 0.86
Comparison of CMT1A and CMT2: similarities and differences. J Neurol (2006) 0.86
Increased Early Systemic Inflammation in ICU-Acquired Weakness; A Prospective Observational Cohort Study. Crit Care Med (2017) 0.86
Fabry disease: a rare cause of neuropathic pain. Curr Pain Headache Rep (2013) 0.85
The AMC Linear Disability Score project in a population requiring residential care: psychometric properties. Health Qual Life Outcomes (2004) 0.85
Severity of Guillain-Barré syndrome is associated with Fc gamma Receptor III polymorphisms. J Neuroimmunol (2005) 0.85
Development of the Stroke-unit Discharge Guideline: choice of assessment instruments for prediction in the subacute phase post-stroke. Int J Rehabil Res (2006) 0.84
Expression of complement components in the peripheral nervous system. Hum Mol Genet (2003) 0.83
Motor unit number estimation using high-density surface electromyography. Clin Neurophysiol (2007) 0.83
The use of a modified Delphi procedure for the determination of 26 prognostic factors in the sub-acute stage of stroke. Int J Rehabil Res (2003) 0.82
Having the vision to measure calcium. J Neurol (2010) 0.82
Myelin and axon pathology in a long-term study of PMP22-overexpressing mice. J Neuropathol Exp Neurol (2011) 0.82
Reduced ADAMTS13 activity in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab (2009) 0.82
Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination pattern. BMC Neurol (2014) 0.82
FabryScan: a screening tool for early detection of Fabry disease. J Neurol (2012) 0.81
Transcriptional profile of the human peripheral nervous system by serial analysis of gene expression. Genomics (2003) 0.81
Hyperglycemia in aneurysmal subarachnoid hemorrhage: a potentially modifiable risk factor for poor outcome. J Cereb Blood Flow Metab (2010) 0.80
Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: is angiographic vasospasm an epiphenomenon? Stroke (2008) 0.80
Chronic idiopathic axonal polyneuropathy revisited. J Neurol (2004) 0.80
Limited upper limb functioning has impact on restrictions in participation and autonomy of patients with hereditary motor and sensory neuropathy 1a. J Rehabil Med (2009) 0.79
Antifibrinolytic therapy for aneurysmal subarachnoid hemorrhage: a major update of a cochrane review. Stroke (2003) 0.79
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review. Lancet Neurol (2002) 0.79
The Academic Medical Center Linear Disability Score item bank: psychometric properties of a new generic disability measure in rheumatoid arthritis. J Rheumatol (2007) 0.79
The immunopathogenesis of paraneoplastic neurological syndromes. Clin Sci (Lond) (2002) 0.79
Guillain-Barré syndrome and its treatment. Expert Rev Neurother (2006) 0.79
Results from a 9-year Intensive Safety Surveillance Scheme (IS(3) ) in miglustat (Zavesca(®) )-treated patients. Pharmacoepidemiol Drug Saf (2015) 0.79
Clinical and myopathological characteristics of desminopathy caused by a mutation in desmin tail domain. Eur Neurol (2012) 0.78
Feasibility and diagnostic accuracy of early electrophysiological recordings for ICU-acquired weakness: an observational cohort study. Neurocrit Care (2015) 0.78
WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Cochrane Database Syst Rev (2009) 0.78
Neurofilaments as a plasma biomarker for ICU-acquired weakness: an observational pilot study. Crit Care (2014) 0.77
Autoimmune limbic encephalitis causing fits, rapidly progressive confusion and hyponatraemia. Age Ageing (2006) 0.77
Walkouts from the emergency department: characteristics, reasons and medical care needs. Eur J Emerg Med (2014) 0.77
Prognostic social factors in the subacute phase after a stroke for the discharge destination from the hospital stroke-unit. A systematic review of the literature. Disabil Rehabil (2004) 0.77
Paraneoplastic neurological antibodies: a laboratory experience. Ann N Y Acad Sci (2005) 0.77
Autoimmunoreactivity to Schwann cells in patients with inflammatory neuropathies. Brain (2003) 0.75
Poikilothermia in a 38-year-old Fabry patient. Clin Auton Res (2010) 0.75
Brain natriuretic peptide is not predictive of dilated cardiomyopathy in Becker and Duchenne muscular dystrophy patients and carriers. BMC Neurol (2013) 0.75
Intravenous immunoglobulin: a first-line treatment in CIDP? Lancet Neurol (2008) 0.75
The cognitive profile of type 1 Gaucher disease patients. J Inherit Metab Dis (2012) 0.75
Tripod pinch strength and thumb opposition are the major determinants of manual dexterity in Charcot-Marie-Tooth disease type 1A. J Neurol Neurosurg Psychiatry (2010) 0.75
Comparison of electrodiagnostic criteria for demyelination in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). J Neurol (2002) 0.75